Skip to content
Catalyst

propranololFinding

Propranolol increases withdrawal due to adverse events

raisesModerate evidenceFinding

01 · The sentence it was drawn from

“We found high certainty evidence that propranolol increases the proportion of patients who discontinue due to adverse events compared to placebo with a risk difference of 0.02 (95% CI 0.00 to 0.03); absolute risk difference: 20 more per 1,000 (95% CI 0 to 30).”
Quoted verbatim from European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.
This finding among the 12 findings on its endpoint

propranolol

Withdrawal due to adverse events

raises

Who
n = 1,291 · Adults with migraine; meta-analysis of 20 randomized trials of oral propranolol versus placebo for migraine prophylaxis
Dose studied
not reported

Moderate evidencePMID 39044170 · 2024

02 · The study

Study
meta-analysis
Participants
1,291
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PK4YKQ1X0D65G1W1XYCAQB